acoustics tests, Questionaries,
Otheracoustics tests at V1 Questionaries at V1
- cognitive
- emotional
- auditory
NCT Number: NCT04717388
the investigators have recently shown that patients with drug-resistant temporal lobe epilepsy who have undergone brain surgery targeting the medial temporal lobe structures were more likely to develop tinnitus postoperatively. This discovery of a vulnerability to tinnitus associated with medial temporal lobe surgery to eliminate drug-refractory epileptic seizures provides a new clinical model of tinnitus, targeting temporal lobe regions as generators or mediators of this hearing disorder. The objective of this project is to study the impact of tinnitus on the cognitive, emotional, psychoacoustic and cerebral functioning associated with this hearing disorder, and to clarify the pathophysiology of tinnitus by comparing different groups of individuals with tinnitus (surgical epileptic patients or non-surgical ORL patients) to matched tinnitus-free groups (surgical tinnitus-free cases and healthy controls volunteer).
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Hôpital Européen Georges Pompidou, Paris, France
Tinnitus (known as "ringing in the ears") is a disabling medical condition. Its psychosocial impact is substantial, including anxiety, depression, stress, irritability, concentration and sleep disorder leading to detrimental effects on communication, education, professional fulfillment, mental health and quality of life. The cerebral bases of tinnitus and its consequence on human hearing health have received a lot of attention in the scientific literature. Yet, the relationship between the neurobiological dysfunction, psychological processes and clinical semiology of tinnitus remains poorly understood. Considering the current gaps in knowledge, there is a real need for clinical investigations into tinnitus-related brain changes and rigorous hearing, psycho-emotional, and cognitive assessments. the investigators recent discovery of a vulnerability to tinnitus associated with medial temporal lobe surgery (to treat refractory epilepsy) provides a new clinical model, which targets the temporal lobe regions as a tinnitus generator or mediator of its severity. The goal of this collaborative interdisciplinary study is to advance knowledge about the pathophysiology of tinnitus, as well as the socio-emotional, cognitive and psychoacoustic aspects associated to this hearing disorder. the investigators will first, characterize the subjective and self-reported hearing disorders with objective psychoacoustic, cognitive and affective measures in tinnitus sufferers and second, clarify the cerebral network underlying tinnitus and elucidate the role temporal lobe regions in the brain networks at play in surgical and non-surgical tinnitus. To this end, individuals with and without tinnitus, who had undergone or not a surgery will be compared in a 2 by 2 design. Investigating different patient cohorts with tinnitus who are well matched to both, healthy control populations and vulnerable clinical populations, without tinnitus is a valuable contribution of our proposal. Moreover, the psychological and hearing profiles of people with tinnitus will be examined in relation with their brain morphology and connectivity profiles.The project builds upon the internationally recognized leadership of the PI and her collaborators in the fields of auditory cognition and its neurobiological bases using neuropsychological, psychoacoustic, and neuroimaging methods in clinical populations. The members of the investigators consortium have all the necessary and unique expertise to carry out this innovative and interdisciplinary project.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Common Criteria for Inclusion :
Group Specific Inclusion Criteria :
Tinnitus+ Group - Suffering from subjective uni- or bilateral tinnitus, chronic (>3 months) and stable (no period of remission).
Chir+ Group
Group Tinnitus-
Exclusion criteria
Additional criteria for patients completing visit V2 :
acoustics tests at V1 Questionaries at V1
Anatomical and functional MRI at V2
Time frame: at the second visit, maximum 6 month after first visit.
Measurement of executive control using a stroop test in people with and without chronic tinnitus.
Time frame: at the second visit, maximum 6 month after first visit.
Measures of Anxiety and Depression using: Hospital Anxiety and Depression Scale (HADS) : 14 rated items from 0 to 3. Seven questions are related to anxiety and seven to the depressive dimension, allowing for thus obtaining two scores (maximum score of each score = 21).
Time frame: at the second visit, maximum 6 month after first visit.
Measurements of auditory functioning through hearing assessment (audiometry) :
Time frame: at the second visit, maximum 6 month after first visit.
Measurements of auditory functioning through hearing assessment (audiometry) :
Time frame: at the second visit, maximum 6 month after first visit.
Measurements of auditory functioning through hearing assessment (audiometry) :
Time frame: at the second visit, maximum 6 month after first visit.
Measurements of auditory functioning through hearing assessment (audiometry) :
Time frame: at the second visit, maximum 6 month after first visit.
Measurements of auditory functioning through hearing assessment (audiometry) :
Time frame: at the second visit, maximum 6 month after first visit.
Measurements of auditory functioning through hearing assessment (audiometry) : Evaluation of transient otoacoustic emissions (TEOAE) or by distortion product (DPOAE)
Time frame: at the second visit, maximum 6 month after first visit.
Measures of cognitive functioning :
ANT gives three attention scores based on reaction times. These scores represent the ability to direct attention, to be alert to surrounding stimuli and the executive part of attention.
Time frame: at the second visit, maximum 6 month after first visit.
Measures of cognitive functioning :
Time frame: at the second visit, maximum 6 month after first visit.
Measures of cognitive functioning :
Measures of cognitive functioning :- Short-term memory score (auditive-verbal span). Score between 1 and 10, where 10 represents the best short-term memory score
Time frame: at the second visit, maximum 6 month after first visit.
Measures of cognitive functioning :
Measures of cognitive functioning :- Working memory score (Brown-Peterson). The Brown Peterson gives a memorization score ranging from 0 to 100, where 100% is the best score.
Time frame: at the second visit, maximum 6 month after first visit.
Measures of cognitive functioning :
Time frame: at the third visit, maximum 18 month after the first visit
Functional and structural brain connectivity measurements using brain imaging (fMRI, diffusion and resting MRI) :
Time frame: at the third visit, maximum 18 month after the first visit
Functional and structural brain connectivity measurements using brain imaging (fMRI, diffusion and resting MRI) :
Time frame: at the third visit, maximum 18 month after the first visit
Functional and structural brain connectivity measurements using brain imaging (fMRI, diffusion and resting MRI) :
Time frame: at the third visit, maximum 18 month after the first visit
Functional and structural brain connectivity measurements using brain imaging (fMRI, diffusion and resting MRI) :
Time frame: at the second visit, maximum 6 month after first visit.
Measures of stress using Perceived Stress Scale (PSS-4): Lowest score: 0, Highest score: 16, Higher scores are correlated to more stress.
Time frame: at the second visit, maximum 6 month after first visit.
Measures of Auditory recognition of emotions using hearing tests with recordings
Contact information is provided by the study sponsor or research team.
Sophie DUPONT, MD, Ph.D
CONTACT
Séverine Samson, Ph.D
CONTACT
Assistance Publique - Hôpitaux de Paris
Other
Cognitive and Emotional Function and Brain Reorganisation Associated to Auditory Abilities : Impact of Tinnitus
Acronym: AudiCog
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06583395
Adnexal Diseases, Amyotrophic Lateral Sclerosis
Palm Desert, California, United States
View Trial DetailsNCT07017998
Ear Diseases, Hearing Disorders
Bozeman, Montana, United States
View Trial DetailsNCT07711639
Dyssomnias, Ear Diseases
Hualien City, Taiwan
View Trial DetailsNCT07071480
Ear Diseases, Hearing Disorders
Miami, Florida, United States
View Trial Details